Serotonin and the blood-vessel wall

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Vascular Biology

Background:

• Hypertension is associated with altered vascular responses to serotonin, a key neurotransmitter.
• Platelets, a primary source of serotonin, exhibit accelerated turnover and impaired removal mechanisms in hypertensive states.
• Functional adaptations in the blood vessel wall and platelets may contribute to elevated peripheral vascular resistance.

Purpose of the Study:

• To investigate the role of serotonin and platelet function in the pathophysiology of chronic hypertension.
• To explore the mechanisms underlying augmented vasoconstrictor responses to serotonin in hypertension.
• To evaluate the potential contribution of these changes to the maintenance of hypertension and its complications.

Main Methods:

• Review of existing literature on serotonin, platelet function, and hypertension.
• Analysis of animal models demonstrating altered vascular responses in hypertensive conditions.
• Examination of the pharmacological effects of S2-serotonergic antagonists like ketanserin.

Main Results:

• Hypertensive states show enhanced vasoconstrictor and diminished vasodilator responses to serotonin.
• Serotonin's constrictor effects are disproportionately increased in hypertension compared to other agonists.
• Impaired endothelial metabolism and platelet uptake slow serotonin removal, increasing its vascular impact.

Conclusions:

• Serotonin and altered platelet dynamics are implicated in the elevated peripheral vascular resistance of chronic hypertension.
• These serotonergic and platelet alterations may contribute to the pathogenesis of hypertensive complications.
• The antihypertensive effects of S2-serotonergic antagonists support serotonin's role in hypertension.